Moreover, neutralizing antibodies raised against HIV-2 can potentially neutralize HIV-1 viruses [57, 58] preventing infection of new CD4+ T-cells and potentially slowing down HIV-1 disease progression. The gene discussed is CD4; the disease is infection.